BCG Unresponsive Intravesical Therapy
Piyush K. Agarwal, MD, explores the evolving landscape of treatments for BCG-unresponsive bladder cancer.
Read MoreSelect Page
Piyush K. Agarwal, MD, earned his medical degree at Weill Cornell Medicine and completed his residency at University Hospital Cleveland Medical Center and a fellowship at MD Anderson Cancer Center. Dr. Agarwal is currently a professor of surgery, the fellowship director for urologic oncology, and the director of the bladder cancer program at the University of Chicago Medicine. Dr. Agarwal specializes in the multidisciplinary management of bladder cancer, using complex surgical techniques, such as robotic and open radical cystectomy and continent urinary diversions, to treat his patients. Along with bladder cancer, Dr. Agarwal is also an expert in all urologic cancers, including prostate, testicular and penile carcinoma.
Dr. Agarwal’s clinical and laboratory research focuses primarily on bladder cancer, specifically BCG-unresponsive disease, the urinary microbiome, molecular targeted therapy and immunotherapy. He has conducted several original, investigator-initiated clinical trials and has presented his research at national and international meetings. Dr. Agarwal has also authored six book chapters and over 90 manuscripts. Additionally, he has served on the FDA’s oncologic drug advisory committee.
Posted by Piyush K. Agarwal | Feb 2025
Piyush K. Agarwal, MD, explores the evolving landscape of treatments for BCG-unresponsive bladder cancer.
Read More